PhenixFIN Corporation - Common Stock (NQ:PFX)
Price and Volume
Detailed Quote| Volume | 2,262 |
| Open | 43.03 |
| Bid (Size) | 43.05 (3,000) |
| Ask (Size) | 45.31 (100) |
| Prev. Close | 45.31 |
| Today's Range | 43.03 - 45.31 |
| 52wk Range | 41.00 - 57.40 |
| Shares Outstanding | 2,019,786 |
| Dividend Yield | 6.43% |
Top News
More News
Performance
More News
Read More
PhenixFIN Q1 Earnings Report: What Investors Need to Know ↗
February 07, 2025
PFX Stock Earnings: PhenixFIN Reported Results for Q4 2023 ↗
December 22, 2023
PhenixFIN Corporation to host Investor Call March 8, 2023
February 13, 2023
Stocks That Hit 52-Week Highs On Wednesday ↗
August 18, 2021
Stocks That Hit 52-Week Highs On Wednesday ↗
June 30, 2021
Frequently Asked Questions
Is PhenixFIN Corporation - Common Stock publicly traded?
Yes, PhenixFIN Corporation - Common Stock is publicly traded.
What exchange does PhenixFIN Corporation - Common Stock trade on?
PhenixFIN Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PhenixFIN Corporation - Common Stock?
The ticker symbol for PhenixFIN Corporation - Common Stock is PFX on the Nasdaq Stock Market
What is the current price of PhenixFIN Corporation - Common Stock?
The current price of PhenixFIN Corporation - Common Stock is 44.50
When was PhenixFIN Corporation - Common Stock last traded?
The last trade of PhenixFIN Corporation - Common Stock was at 12/31/25 01:27 PM ET
What is the market capitalization of PhenixFIN Corporation - Common Stock?
The market capitalization of PhenixFIN Corporation - Common Stock is 89.88M
How many shares of PhenixFIN Corporation - Common Stock are outstanding?
PhenixFIN Corporation - Common Stock has 90M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.